| 2157 |
1793: AP-1 activation |
1795: TGFbeta expression |
Jul 9, 2020 |
Jul 9, 2020 |
1 AOP
|
| 301 |
272: Activation/Proliferation, T-cells |
312: N/A, Allergic contact dermatitis on challenge |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 835 |
272: Activation/Proliferation, T-cells |
827: sensitisation, skin |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 1701 |
272: Activation/Proliferation, T-cells |
313: Increase, Allergic Respiratory Hypersensitivity Response |
Dec 7, 2017 |
Aug 1, 2022 |
1 AOP
|
| 3332 |
272: Activation/Proliferation, T-cells |
2256: Activation of gluten- and TG2-reactive B cells |
Aug 13, 2024 |
Aug 13, 2024 |
None
|
| 3334 |
272: Activation/Proliferation, T-cells |
1931: Disruption of the intestinal barrier |
Aug 13, 2024 |
Aug 13, 2024 |
None
|
| 3337 |
272: Activation/Proliferation, T-cells |
2252: Formation of HLA-DQ2/8-gluten complexes |
Aug 13, 2024 |
Aug 13, 2024 |
None
|
| 1652 |
1469: TGFbeta pathway activation |
1456: Differentiation of fibroblasts |
Aug 16, 2017 |
Aug 16, 2017 |
1 AOP
|
| 1653 |
1469: TGFbeta pathway activation |
1457: EMT |
Aug 16, 2017 |
Aug 16, 2017 |
1 AOP
|
| 1832 |
1576: Activation, Tissue resident cells (Kuppfer cells) |
1579: Increase, proinflammatory mediators (TNFalpha) |
Jan 7, 2019 |
Jan 7, 2019 |
1 AOP
|
| 1370 |
1283: Activation, TGF-beta pathway |
1277: Reproductive failure |
Feb 15, 2017 |
Feb 15, 2017 |
1 AOP
|
| 2153 |
1283: Activation, TGF-beta pathway |
1457: EMT |
Jul 9, 2020 |
Jul 9, 2020 |
1 AOP
|
| 1016 |
978: Activation, Suppression of NFAT activation and hindrance of nuclear localization |
979: Interference, nuclear localization of NFAT |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 1868 |
1606: Activation, Stellate cell |
1549: Liver Injury |
Mar 6, 2019 |
Mar 6, 2019 |
1 AOP
|
| 3733 |
1606: Activation, Stellate cell |
68: Increase, Collagen accumulation |
Feb 11, 2026 |
Feb 11, 2026 |
None
|
| 294 |
264: Activation, SREBP-1c |
89: Synthesis, De Novo Fatty Acid (FA) |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 1397 |
1301: Activation, SREBP-1 |
1304: Activation, FXR |
Apr 12, 2017 |
Apr 12, 2017 |
None
|
| 1403 |
1301: Activation, SREBP-1 |
258: Activation, SCD-1 |
Apr 12, 2017 |
Apr 12, 2017 |
None
|
| 482 |
457: Activation, SREBF1 |
458: Increased, De Novo FA synthesis |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 489 |
457: Activation, SREBF1 |
462: Up Regulation, SCD-1 |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 1662 |
457: Activation, SREBF1 |
459: Increase, Liver steatosis |
Aug 31, 2017 |
Aug 31, 2017 |
1 AOP
|
| 987 |
924: Activation, Sp1 |
962: Increase, Mucin production |
Nov 29, 2016 |
Aug 11, 2021 |
None
|
| 896 |
480: Activation, SHP |
878: Inhibition, SREBP1c |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 1409 |
480: Activation, SHP |
227: Activation, PPARα |
Apr 12, 2017 |
Apr 12, 2017 |
None
|
| 1412 |
480: Activation, SHP |
1307: Inhibition, LXR |
Apr 12, 2017 |
Apr 12, 2017 |
None
|